NCT06148675Completed
Macrowire for IntracraNial Thrombectomy
MINT Registry : Macrowire for IntracraNial Thrombectomy
Source: ClinicalTrials.gov · Last updated 10 Nov 2025
Brief summary (registry, in English)
The aim of this study is to develop a multicenter database of patient data and outcomes for patients undergoing intracranial thrombectomy for acute ischemic stroke secondary to emergent large vessel occlusion with delivery of reperfusion catheter over a novel macrowire (Aristotle Colossus) to perform intracranial mechanical thrombectomy.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 105 (actual)
- First submitted
- 20 Nov 2023
- Start date
- 25 May 2023
- Primary completion date
- 31 Mar 2025
- Lead sponsor
- Indiana University
- Diseases
- Stroke
- NCT number
- NCT06148675
What you commit to
- Study type: Observational
- Participants enrolled: 105
- From 25 May 2023 to the primary completion date, 31 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Age
- Age \<18 years or \>85 years Unknown time of onset NIHSS \< 5 CT ASPECTS \<5 Pre-stroke morbidity, modified Rankin score \> 2 Tandem occlusion
Who the study is looking for
- Age \>18-85 years Time of onset \< 24 hours Acute stroke patient with NIHSS \>6 CT-ASPECTS ≥ 6 Proven intracranial occlusion - (ICA-T, M1) Modified Rankin score: 0-2
Age in the registry: 18 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Indiana University Methodist Hospital Coordinator of this site? Confirm its status | Indianapolis | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.